Rising Prevalence of Chronic Diseases Driving Vietnam Diagnostic Tests Market Growth

Vietnam Diagnostic Tests Market Overview, Trends, Size and Forecast: 2025-2030

The Vietnam Diagnostic Tests Market size was valued at around USD1.84 billion in 2024 and is expected to reach USD6.79 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 24.31% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The market growth is driven by several growth factors, such as the rising prevalence of non-communicable and infectious diseases, such as Tuberculosis, diabetes, chronic kidney disorders, cardiovascular diseases, liver disease, cancer, etc., in the country, the implementation of different government policies, the rapid shift towards technological advancements, including the integration of artificial intelligence with the diagnostic software, tools & platforms, the inclination towards digitalization. One of the most prominent growth factors is the increasing public awareness regarding early detection, increasing the regular screenings and check-ups, thus contributing to the market growth & expansion.

Additionally, the government of the country is significantly supporting the market growth by allocating a substantial amount of funds for the development of healthcare infrastructure under various policies such as the National Pharmaceutical Industry Strategy, the National Strategy for Healthcare Development, etc. These initiatives are offering lucrative growth opportunities, thus contributing to the potential market growth. Moreover, the rising shift towards digitalization and the adoption of artificial intelligence in diagnostic tools and equipment, which are increasing the efficiency of diagnostic tests over traditional tests, is gaining momentum in this market. However, the limited infrastructure and the high cost of diagnostic tests in Vietnam are hindering the market growth, further states the research report, “Vietnam Diagnostic Tests Market Analysis, 2025.”

Vietnam Diagnostic Tests Market Segmentation Insights:

Immunoassay-based Diagnostic Tests Generating Market Demand

Based on product type, the market is further segmented into Immunoassay-Based Diagnostic Tests, Molecular Diagnostic Tests, Clinical Chemistry Diagnostic Tests, Hematology Diagnostic Tests, Microbiology Diagnostic Tests, Rapid/Point-of-Care Diagnostic Tests, and Others. Out of these, the market immunoassay-based diagnostic tests are dominating the market, accounting for around 30% of the market share. This segment is dominating due to the quick patient outcomes and high accuracy of these tests over other types of diagnostic tests. This has led to a high preference for the immunoassay-based diagnostic tests in Vietnam.

Additionally, the high incidence of diseases such as HIV, Tuberculosis, hepatitis B & C in the country is heavily dependent on the immune-based tests, due to their faster and accurate outcomes, thus increasing the market growth. Moreover, these tests typically require samples in trace amounts because of the high sensitivity of these tests. This is leading to their cost-effectiveness as compared to other tests. Therefore, the immunoassay-based diagnostic tests are dominating the market.

Hospital-based Laboratories Hold the Largest Market Share

Among these, the hospital-based laboratories are leading the market with a market share of around 50%. The dominance is due to the encounter of a large patient volume simultaneously in the hospital settings, which is increasing the market demand, including advanced diagnostic tests, thus contributing to the dominance of hospital-based laboratories.

Additionally, the Vietnamese government is significantly allocating funds for the development of healthcare infrastructure, targeting to increase the diagnostic tools, software, and machinery in the hospital settings. Also, the large space settings of hospitals allow the easy installation of large-sized diagnostic imaging tools, such as MRI machines, CT scanners, etc., which is not easily possible for home-care settings and other end users, thus hospital-based laboratories are dominating this market.

Top Companies in the Vietnam Diagnostic Tests Market

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading Vietnam Diagnostic Tests Market companies, including Roche Vietnam Co., Ltd., Siemens Healthineers (Vietnam) Co., Ltd., Abbott Laboratories S.A. (Vietnam), Danaher Corporation (Beckman Coulter Vietnam), Becton, Dickinson and Company (BD Vietnam), Thermo Fisher Scientific (Vietnam), Bio-Rad Laboratories (Vietnam), Medtronic Vietnam, Viet A Corporation, Medicon Co., Ltd, Sao Thai Duong Joint Stock Company, and others, are looking forward to increasing their market size & share.

Key Questions Answered in the Research Report

What is the scope, size, value, and forecast of the Vietnam Diagnostic Tests Market?
What is the volume and share of each segment in the Vietnam Diagnostic Tests Market?
What are the key trends shaping the Vietnam Diagnostic Tests Market from 2025 to 2030?
What growth factors and risks impact the Vietnam Diagnostic Tests Market?
What are the main challenges faced by players in the Vietnam Diagnostic Tests Market?
What are the top opportunities in the Vietnam Diagnostic Tests Market?
What does competitive analysis reveal about the Vietnam Diagnostic Tests Market landscape?
Who are the key players and companies leading the Vietnam Diagnostic Tests Market?
What innovations are transforming the future dynamics of the Vietnam Diagnostic Tests Market?
How are partnerships and collaborations driving the Vietnam Diagnostic Tests Market growth?
How does the Vietnam Diagnostic Tests market differ based on geography and segments?